BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 23082029)

  • 1. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
    Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
    Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.
    White NM; Khella HW; Grigull J; Adzovic S; Youssef YM; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Jewett MA; Evans AJ; Gabril M; Yousef GM
    Br J Cancer; 2011 Nov; 105(11):1741-9. PubMed ID: 22033272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
    Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
    J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
    Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma.
    Karamchandani JR; Gabril MY; Ibrahim R; Scorilas A; Filter E; Finelli A; Lee JY; Ordon M; Pasic M; Romaschin AD; Yousef GM
    Hum Pathol; 2015 May; 46(5):673-80. PubMed ID: 25704627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic profiling identifies potential prognostic factors for human clear cell renal cell carcinoma.
    Sun X; Zhang H; Luo L; Zhong K; Ma Y; Fan L; Fu D; Wan L
    Oncol Rep; 2016 Dec; 36(6):3131-3138. PubMed ID: 27748938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.
    White NM; Newsted DW; Masui O; Romaschin AD; Siu KW; Yousef GM
    Tumour Biol; 2014 Mar; 35(3):1833-46. PubMed ID: 24136743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis.
    White NM; Masui O; Newsted D; Scorilas A; Romaschin AD; Bjarnason GA; Siu KW; Yousef GM
    Br J Cancer; 2014 Mar; 110(5):1250-9. PubMed ID: 24496460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
    White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
    Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
    Lee CT; Genega EM; Hutchinson B; Fearn PA; Kattan MW; Russo P; Reuter VE
    Urol Oncol; 2003; 21(3):179-84. PubMed ID: 12810203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
    Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
    Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis markers for metastatic renal cell carcinoma: quantitative proteomics approach.
    Dihazi H
    Expert Rev Proteomics; 2013 Feb; 10(1):21-4. PubMed ID: 23414356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of TIM-3 between primary and metastatic sites in renal cell carcinoma.
    Zhang X; Yin X; Zhang H; Sun G; Yang Y; Chen J; Shu K; Zhao J; Zhao P; Chen N; Wang J; Shen P; Zeng H
    BMC Cancer; 2019 Jan; 19(1):49. PubMed ID: 30630458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome.
    Laird A; O'Mahony FC; Nanda J; Riddick AC; O'Donnell M; Harrison DJ; Stewart GD
    PLoS One; 2013; 8(4):e60483. PubMed ID: 23577117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.